Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Oilfield Chemicals ...

Argobio Studio, the launch platform for Europe's best innovative science, today announced the successful seed financing of Enodia Therapeutics, a ...

Argobio successfully facilitated fundraising and syndication process, following its earlier role in creating and pre-seed funding EnodiaFinancing ...

Dr. Henryk Krajewski is an executive director and global capability lead for top team performance at Russell Reynolds Associates. He works with CEOs and executive teams on how to improve trust, ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Delaware’s Court of Chancery, on December 16, 2025, tossed key HKA claims, ruling its non-compete and “encouragement” non-solicit clause to be facially overbroad and unenforceable. In HKA Global, LLC ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.